Enoxolone
- Generic Name
- Enoxolone
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C30H46O4
- CAS Number
- 471-53-4
- Unique Ingredient Identifier
- P540XA09DR
- Background
Enoxolone (glycyrrhetic acid) has been investigated for the basic science of Apparent Mineralocorticoid Excess (AME).
- Associated Conditions
- Inflammation of Mouth
- Associated Therapies
- -
Enoxolone in Major Depression - Biomarker-outcome Relationship
- First Posted Date
- 2022-10-06
- Last Posted Date
- 2024-04-09
- Lead Sponsor
- Philipps University Marburg Medical Center
- Target Recruit Count
- 60
- Registration Number
- NCT05570110
- Locations
- 🇩🇪
Clinic for Psychiatry and Psychotherapy, Marburg, Hessen, Germany
The Role of Mineralocorticoid Receptors in Vascular Function
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2008-09-25
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Brigham and Women's Hospital
- Target Recruit Count
- 15
- Registration Number
- NCT00759525
- Locations
- 🇺🇸
Brigham and Women's Hospital, Boston, Massachusetts, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath